BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2020
View Archived Issues
Butyrate affects regulatory B cells, rheumatoid arthritis
Read More
Lamin A/C's presence in nucleus, absence from membrane both problematic in progeria
Read More
New animal model more accurate for assessing nerve agent poisoning countermeasures
Read More
Screening opens in U.K. for first-in-human study of COVID-19 vaccine candidate ChAdOx1 nCoV-19
Read More
FDA approves Taltz for pediatric patients with plaque psoriasis
Read More
SMOC1 as a novel therapeutic target in atopic dermatitis
Read More
ISA-101 vaccine demonstrates promising efficacy in advanced cervical cancer
Read More
New serine-protein kinase ATM inhibitors disclosed by Suzhou Zanrong Pharma
Read More
Jiangsu Chia Tai Tianqing Pharmaceutical Group patents BTK inhibitors
Read More
Chengdu Origin Biotechnology discovers proteosome inhibitors
Read More
New melanocortin MC4 receptor agonists synthesized at Novo Nordisk
Read More
Roche identifies new HBV cccDNA inhibitors
Read More
Structural studies show similarities and differences in SARS, COVID-19 receptor binding
Read More
New Parkinson's disease model induced via dysregulation in dopamine sequestration
Read More
Researchers identify biomarkers for monitoring progression of colorectal cancer
Read More
HMPL-453 begins new phase II study in China for advanced malignant mesothelioma
Read More
Inovio reports phase II interim data on VGX-3100 in HPV-related vulvar dysplasia
Read More
Golden Biotech advances phase I/II study of antroquinonol for stage IV metastatic pancreatic cancer
Read More
Interim phase I data show confirmed responses with XMT-1536 in pretreated ovarian cancer and NSCLC
Read More
DNASE1L3 is a diagnostic marker of ankylosing spondylitis
Read More
European Commission approves Nubeqa for nonmetastatic castration-resistant prostate cancer
Read More
Otsuka studies OPC-214870 in subjects with history of photoparoxysmal response on EEG
Read More